Radiation-Related Dysphagia Development Prediction Using a Two-Step Ultrasonographic Model (R-2D-2)

Launched by HOPITAL FORCILLES · Apr 24, 2024

Keywords

ClinConnect Summary

This clinical trial, called R-2D-2, is studying how to predict swallowing difficulties that can occur in patients receiving radiotherapy for head and neck cancers. These swallowing problems can significantly affect a person's ability to eat, their nutrition, and their overall quality of life. The researchers are exploring a new method using ultrasound imaging, which is a non-invasive and safe way to assess the swallowing-related structures in the throat. This method aims to provide better early detection of swallowing issues, which can lead to more personalized and effective treatment plans.

To participate in this study, individuals must be at least 18 years old and undergoing radiotherapy for head and neck cancer at Hôpital Forcilles. They should not have any neurological disorders or pre-existing swallowing problems before starting treatment. Participants will undergo several assessments, including weekly swallowing tests and ultrasound evaluations at different points during their treatment. This study is an important step in improving care for patients undergoing radiotherapy by using ultrasound to help predict and manage swallowing difficulties more effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients admitted to Hôpital Forcilles for head and neck cancer radiotherapy;
• • Ultrasound operator available ;
• • Patient at least 18 years old at the time of inclusion;
• • Membership of a social security scheme or beneficiary of such a scheme ;
• • Oral, free, informed and express patient consent.
• Exclusion Criteria:
• • Patients with neurological disorders;
• • Patients with DR before the start of radiotherapy;
• • Patient's refusal to participate in the study ;
• • Person subject to a safeguard of justice measure ;
• • Patient under guardianship;
• • Patient with limited care.